or Try an Advanced Search...

    Technical Analysis for ABIO - ARCA biopharma, Inc.

    Grade Last Price % Change Price Change
    A 3.54 1.72% 0.06
    ABIO closed down 4.13 percent on Thursday, April 25, 2024, on 3 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Up
    Historical ABIO trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 1.72%
    NR7 Range Contraction -2.48%
    Inside Day Range Contraction -2.48%
    Wide Bands Range Expansion -2.48%
    New 52 Week Closing High Bullish -3.01%
    Earnings Movers Other -3.01%
    Wide Bands Range Expansion -3.01%
    Up 3 Days in a Row Strength -3.01%
    Up 4 Days in a Row Strength -3.01%
    New 52 Week Closing High Bullish 2.61%
    Older End-of-Day Signals for ABIO ...

       Recent Intraday Alerts

    Alert Time
    Gapped Up (Full) about 2 hours ago
    Rose Above Previous Day's High about 2 hours ago
    Up 5% about 2 hours ago
    Up 3% about 2 hours ago
    Up 2% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ABIO Chart by TradingView
    Basic chart:

    Profile

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Cardiac Arrhythmia Atrial Fibrillation Ventricular Dysfunction

    Is ABIO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 3 Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details
    Apr 3 ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction
    Apr 3 ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
    Dec 20 We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
    See more ABIO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.88
    52 Week Low 1.56
    Average Volume 1,782,798
    200-Day Moving Average 1.97
    50-Day Moving Average 2.23
    20-Day Moving Average 3.05
    10-Day Moving Average 3.38
    Average True Range 0.21
    RSI (14) 73.19
    ADX 66.07
    +DI 43.40
    -DI 8.55
    Chandelier Exit (Long, 3 ATRs) 3.26
    Chandelier Exit (Short, 3 ATRs) 2.31
    Upper Bollinger Bands 4.19
    Lower Bollinger Band 1.90
    Percent B (%b) 0.69
    BandWidth 75.31
    MACD Line 0.41
    MACD Signal Line 0.40
    MACD Histogram 0.0106
    Fundamentals Value
    Market Cap 50.46 Million
    Num Shares 14.5 Million
    EPS -0.37
    Price-to-Earnings (P/E) Ratio -9.41
    Price-to-Sales 0.00
    Price-to-Book 0.65
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.85
    Resistance 3 (R3) 3.87 3.76 3.79
    Resistance 2 (R2) 3.76 3.67 3.76 3.77
    Resistance 1 (R1) 3.62 3.61 3.57 3.60 3.75
    Pivot Point 3.52 3.52 3.49 3.51 3.52
    Support 1 (S1) 3.37 3.42 3.32 3.36 3.21
    Support 2 (S2) 3.27 3.36 3.26 3.19
    Support 3 (S3) 3.13 3.27 3.17
    Support 4 (S4) 3.11